The US Food and Drug Administration (FDA) has announced its intention to introduce a new “risk-based enforcement approach” to protect consumers from unproven homeopathic products that could be potentially harmful to their health.  According to the Center for Drug Evaluation and...

Pharmacies in the United States will soon stock two more medications for treating type 2 diabetes after pharmaceutical giants Merck and Pfizer had a pair of products approved by the US Food and Drug Administration (FDA). Steglujan (ertugliflozin and sitagliptin) and Steglatro (ertugliflozin) were...

Giapreza (angiotensin II) injection is now approved for treatment of dangerously low blood pressure in adults with septic or other forms of distributive shock. The intravenous infusion gained US Food and Drug Administration (FDA) approval following a clinical trial of 321 patients with shock and a...

Sanofi’s Admelog (insulin lispro injection) is the first short-acting “follow-on” insulin product for diabetes treatment to gain approval from the US Food and Drug Administration (FDA). The rapid-acting insulin is similar to Humalog and is indicated to improve blood sugar control...

A cheaper generic version of erectile dysfunction drug Viagra (sildenafil citrate) is now available in the United States. Sildenafil is a PDE-5 inhibitor, which works by relaxing the blood vessels and facilitating easier blood flow to the penis.  The branded drug Viagra is manufactured by...

Aurobindo Pharma has received US Food and Drug Administration approval for its quetiapine fumarate extended-release tablets (50mg, 150mg, 200mg, 300mg, and 400mg). The medication is a bioequivalent of the AstraZeneca drug Seroquel XR and is therapeutically equivalent to this...

The US Food and Drug Administration (FDA) has approved Sunovion’s Lonhala Magnair (glycopyrrolate), making it the first nebulized long-acting muscarinic antagonist (LAMA) treatment in the United States for patients with chronic obstructive pulmonary disease (COPD). It is expected to appear in...

The US Food and Drug Administration (FDA) has approved the Auvi-Q (epinephrine injection USP) 0.1mg auto-injector as a treatment for life-threatening allergic reactions in children and infants. The Kaléo product was granted Priority Review by the FDA and is expected to be available in...

The US Food and Drug Administration has granted approval to Sublocade (buprenorphine extended release) for the treatment of patients with moderate to severe opioid use disorder. Shaun Thaxter, chief executive officer of Indivior, described the approval as an “important step forward for...

More than four in ten (42 percent) of cancer cases in the United States are linked to risk factors associated with cancer, such as smoking, obesity, poor diet, ultraviolet radiation and physical inactivity, according to a new study conducted by the American Cancer Society. The results of the...

Adults with type 1 or type 2 diabetes have a new treatment option available to them following the US Food and Drug Administration’s (FDA) decision to approve Novo Nordisk's rapid-acting mealtime insulin Fiasp (insulin aspart).  The drug is indicated to improve glycemic control in adults...

The US Food and Drug Administration (FDA) has extended the approval of Pfizer’s drug Sutent (sunitinib malate) as an adjuvant treatment for adults at a high risk of experiencing a return of renal cell carcinoma following the removal of a kidney.  Adjuvant therapies are treatments...

The US Food and Drug Administration (FDA) has approved the first once-daily, two-drug single pill treatment for certain patients with human immunodeficiency virus type 1 (HIV-1). Approval for Juluca (dolutegravir and rilpivirine) was granted to ViiV Healthcare, a global specialist in HIV owned by...

A new treatment option is available to certain patients with hemophilia A following the US Food and Drug Administration’s (FDA) approval of Genentech’s drug Hemlibra (emicizumab-kxwh). The medication is approved for treatment of patients with hemophilia A who have developed Factor VIII...

The US Food and Drug Administration (FDA) Advisory Committee has voted 16-0 to approve semaglutide as a once-weekly treatment to improve glycemic control in adults with type 2 diabetes. Novo Nordisk submitted the application in December 2016 under the FDA’s Prescription drug user Fee Act...

Around 49 million American adults were still using tobacco products in 2015, according to new data published by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration’s (FDA) Center for Tobacco Products.  The Morbidity and Mortality Weekly Report...

The US Food and Drug Administration (FDA) has approved a new once-daily single inhaler triple therapy for treatment of certain adults with chronic obstructive pulmonary disease (COPD).  Trelegy Ellipta (furoate, umeclidinium, vilanterol) is indicated for patients on a fixed-dose combination...

The US Food and Drug Administration (FDA) has approved the first continuous glucose monitoring system for adult patients with diabetes. The FreeStyle Libre Flash Glucose Monitoring System enables patients to make decisions about their treatment without needing to calibrate using fingerstick...

The 14th National Prescription Drug Take Back Day held on October 28th, 2017 has been hailed as the most successful yet, retrieving record quantities of unused medication. Run by the Drug Enforcement Agency (DEA), the events highlight the importance of proper disposal of unwanted drugs and provide...

Zelboraf (vemurafenib) has been approved for treatment of adult patients with a rare cancer of the blood. It is the first medication approved by the US Food and Drug Administration (FDA) for treatment of Erdheim-Chester Disease (ECD).  ECD is a rare blood cancer originating in the bone...